Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep 19;452(2):276-86.
doi: 10.1016/j.bbrc.2014.07.086. Epub 2014 Jul 29.

Integrative genomics of chronic obstructive pulmonary disease

Affiliations
Review

Integrative genomics of chronic obstructive pulmonary disease

Brian D Hobbs et al. Biochem Biophys Res Commun. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex disease with both environmental and genetic determinants, the most important of which is cigarette smoking. There is marked heterogeneity in the development of COPD among persons with similar cigarette smoking histories, which is likely partially explained by genetic variation. Genomic approaches such as genomewide association studies and gene expression studies have been used to discover genes and molecular pathways involved in COPD pathogenesis; however, these "first generation" omics studies have limitations. Integrative genomic studies are emerging which can combine genomic datasets to further examine the molecular underpinnings of COPD. Future research in COPD genetics will likely use network-based approaches to integrate multiple genomic data types in order to model the complex molecular interactions involved in COPD pathogenesis. This article reviews the genomic research to date and offers a vision for the future of integrative genomic research in COPD.

Keywords: Chronic obstructive pulmonary disease; Genomewide association study; Genomics; Network medicine.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr. Hersh reports lecture fees from Novartis and consulting fees from CSL Behring. Dr. Hobbs reports no competing interests.

Figures

Figure 1
Figure 1
Three generations of genomic studies, described by Silverman and Loscalzo. (Discovery Medicine 2012:14:143-152). Figure reproduced with permission.

References

    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. - PMC - PubMed
    1. Burrows B, Knudson RJ, Cline MG, et al. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1977;115:195–205. - PubMed
    1. DeMeo DL, Silverman EK. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax. 2004;59:259–264. - PMC - PubMed
    1. Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360:2749–2757. - PubMed
    1. Hersh CP, DeMeo DL, Silverman EK. Chronic Obstructive Pulmonary Disease. In: Silverman EK, Shapiro SD, Lomas DA, Weiss ST, editors. Respiratory Genetics. Hodder Arnold; New York: 2005. pp. 253–296.

Publication types

MeSH terms

Substances